Cargando…
Aprotinin Inhibits Thrombin Generation by Inhibition of the Intrinsic Pathway, but is not a Direct Thrombin Inhibitor
Background Aprotinin is a broad-acting serine protease inhibitor that has been clinically used to prevent blood loss during major surgical procedures including cardiac surgery and liver transplantation. The prohemostatic properties of aprotinin likely are related to its antifibrinolytic effects, bu...
Autores principales: | Lisman, Ton, Adelmeijer, Jelle, Huskens, Dana, Meijers, Joost C. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407936/ https://www.ncbi.nlm.nih.gov/pubmed/34485811 http://dx.doi.org/10.1055/s-0041-1735154 |
Ejemplares similares
-
Differential In Vitro Inhibition of Thrombin Generation by Anticoagulant Drugs in Plasma from Patients with Cirrhosis
por: Potze, Wilma, et al.
Publicado: (2014) -
Inhibition of Intrinsic Thrombin Generation
por: Stief, Thomas W.
Publicado: (2006) -
Ximelagatran: Direct Thrombin Inhibitor
por: Ho, Shir-Jing, et al.
Publicado: (2006) -
Intrinsic coagulation pathway-mediated thrombin generation in mouse whole blood
por: Konrath, Sandra, et al.
Publicado: (2022) -
Reversible covalent direct thrombin inhibitors
por: Sivaraja, Mohanram, et al.
Publicado: (2018)